Approvals/TGA/CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled syringe

Approved

STANDARD

CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled syringe

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f4a1806741417e1b
Product Name: CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled syringe
Artg Id: 373065
Artg Name: CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled syringe
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2022-09-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f4a1806741417e1b

Type

Standard